Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology-03-02-2003
Volume27
Issue 3

Standards for Supplements

Author(s):

Jill Wechsler

Concerns about the safety and efficacy of dietary and herbal products are generating manufacturing requirements and analytical standards for ingredients.

External Link - article-49254.pdf

Articles in this issue
The Clarification of Bioreactor Cell Cultures for Biopharmaceuticals
Standards for Supplements
Concept Paper Discusses Update of Aspetic Processing Guidelines
Outsourcing Outlook March 2003
A Review of Classification of Emerging Excipients in Parenteral Medications
March 2003

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
Ozempic, Mounjaro and Wegovy injectable pens on white background | Image Credit: © K KStock - stock.adobe.com
September 17th 2025

Lilly, Novo, Hims Get FDA Warnings About Misleading Drug Communications

Patrick Lavery
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
September 17th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Scientist Managing Prescription Drug Supply Chain | Image Credit: © leowolfert - stock.adobe.com
September 17th 2025

AI and Digital Oversight in Pharma Supply Chains: PDA Regulatory Conference Insights

Patrick Lavery
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
September 17th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | Image Credit: © Tada Images - stock.adobe.com
September 17th 2025

FDA Initiates Real-Time CRL Publication: What It Means for Drug Developers

Patrick Lavery
Doctor technology AI integrates big data analytics with clinical research, enabling precise treatment plans tailored to individual patient needs and genetic profiles. | Image Credit: © Suriyo - stock.adobe.com
September 17th 2025

Pistoia Alliance Announces Agentic AI Collaboration Initiative

Patrick Lavery
© 2025 MJH Life Sciences

All rights reserved.